- Featured Product
- KD/KO Validated
CXCL16 Monoklonaler Antikörper
CXCL16 Monoklonal Antikörper für WB,ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human, Maus und mehr (1)
Anwendung
WB, IHC, IF, ELISA
Konjugation
Unkonjugiert
CloneNo.
2H7B3
Kat-Nr. : 60123-1-Ig
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | SH-SY5Y-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 1 publications below |
WB | See 2 publications below |
IHC | See 1 publications below |
IF | See 1 publications below |
Produktinformation
60123-1-Ig bindet in WB, IHC, IF, ELISA CXCL16 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
In Publikationen genannte Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Maus / IgG2a |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | CXCL16 fusion protein Ag4883 |
Vollständiger Name | chemokine (C-X-C motif) ligand 16 |
Berechnetes Molekulargewicht | 273 aa, 30 kDa |
Beobachtetes Molekulargewicht | 35 kDa, 60 kDa |
GenBank-Zugangsnummer | BC017588 |
Gene symbol | CXCL16 |
Gene ID (NCBI) | 58191 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Caprylsäure/Ammoniumsulfat-Präzipitation |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CXCL16 is a recently discovered cytokine belonging to the CXC chemokine family, which is synthesised in plasmacytoid dendritic cell as a transmembrane molecule. It exists in a transmembrane and soluble form. The transmembrane form of CXCL16 functions as an adhesion molecule for CXCR6-expressing cells, whereas the soluble form of CXCL16 mediates infiltration of circulating cells into sites of injury. CXCL16, has been proposed as an important pathogenic mediator in inflammatory diseases, including rheumatoid arthritis, glomerulonephritis, or prostate cancer. CXCL16 has been implicated in some forms of renal disease such as lupus nephritis and antiglomerular basement membrane nephritis. CXCL16 also plays a pivotal role in the pathogenesis of angiotensin II-induced renal injury and fibrosis through regulation of macrophage and T cell infiltration and bone marrow-derived fibroblast accumulation.
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for CXCL16 antibody 60123-1-Ig | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Cancer Commun (Lond) Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma | ||
FASEB J Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation. | ||
Mol Med Rep oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.
| ||
Cardiovasc Diabetol Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease |